With full membership, watch our educational and editorial videos, search the site, receive our newsletters, join discussions, download slides and much more.
Read Dr. Kalaitzidis' review of the role of hypertension in the cardiovascular risk continuum, then watch Drs. Weber, Mancia, Williams, and Haller as they present the latest treatment options and preview important clinical trial data.
Microalbuminuria does not only signal worsening renal function but is an important marker in cardiovascular risk assessment. Join our expert panel, Drs. Izzo, Ruilope, and Weir as they discuss the interplay of diabetes and hypertension on the cardiovascular risk continuum.
Join Drs. Weber, Basile, and Gradman as they discuss methods of overcoming clinical inertia and strategies to ensure that more patients achieve their blood pressure goals.
From prehypertension to heart failure the data from ARB outcome trials continue to accumulate. So what's next? With Drs Giles and Izzo
Acknowledgements
CME provider: The American Society of Hypertension, Inc.
Combination therapy clinical theme is supported by an independent educational grant from Forest Pharmaceuticals, Inc., and Daiichi-Sankyo.
Steering committee
The steering committee members are active in overseeing the development and direction of this educational series.